ERK-mediated phosphorylation of fibroblast growth factor receptor 1 on Ser777 inhibits signaling

Malgorzata Zakrzewska1, Ellen Margrethe Haugsten, Beata Nadratowska-Wesolowska

  • 1Centre for Cancer Biomedicine, Faculty of Medicine, University of Oslo, 0310 Oslo, Norway.

Science Signaling
|February 14, 2013
PubMed

Insights

Fibroblast growth factor 1 (FGF1) signaling is regulated by a negative feedback loop. Extracellular signal-regulated kinases (ERK1/2) phosphorylate FGFR1 at Ser777, reducing FGF receptor signaling and protecting cells from overactivation.

Area of Science:

  • Cellular signaling
  • Molecular biology
  • Signal transduction

Background:

  • Fibroblast growth factor 1 (FGF1) activates cell signaling via fibroblast growth factor receptors (FGFRs).
  • FGFR activation involves tyrosine phosphorylation and downstream mitogen-activated protein kinase (MAPK) cascades.
  • FGFRs possess a serine-rich C-terminal tail crucial for regulatory mechanisms.

Purpose of the Study:

  • To elucidate a novel regulatory mechanism of FGFR signaling.
  • To investigate the role of C-terminal serine phosphorylation in FGFR1 activity.
  • To identify crosstalk mechanisms influencing FGFR signaling.

Main Methods:

  • Site-directed mutagenesis to create FGFR1 mutants (Ser777 to alanine, phosphomimetic).
  • Analysis of receptor tyrosine phosphorylation and MAPK activation.
  • Assessment of cellular responses including proliferation, migration, and axonal growth.

Main Results:

  • Phosphorylation of Ser777 in FGFR1 by ERK1 and ERK2 was identified as a key regulatory event.
  • Preventing Ser777 phosphorylation or mutating it to alanine enhanced FGF-stimulated receptor phosphorylation and downstream cellular activities.
  • A phosphomimetic mutation at Ser777 reduced FGFR1 signaling.
  • MAPK activation by other receptor tyrosine kinases led to Ser777 phosphorylation, indicating crosstalk regulation.

Conclusions:

  • A negative feedback mechanism involving Ser777 phosphorylation of FGFR1 by MAPKs (ERK1/2) controls FGF signaling.
  • This mechanism prevents excessive FGFR activation, safeguarding cellular processes.
  • The findings reveal crosstalk integration into FGFR signaling pathways.

Related Concept Videos

Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...